Ad
related to: pharmacology journals with impact factor higher than 10 years
Search results
Results from the WOW.Com Content Network
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
As of 2023, Annual Review of Pharmacology and Toxicology is being published as open access, under the Subscribe to Open model. [1] As of 2024, Journal Citation Reports lists the journal's 2023 impact factor as 11.2, ranking it second of 106 journal titles in the category "Toxicology" and ninth of 354 titles in the category "Pharmacology ...
Current Drug Metabolism is a peer-reviewed medical journal covering the study of drug metabolism. It was established in 2000 and is published 10 times per year by Bentham Science Publishers. The editor-in-chief is Ming Hu [2] (University of Houston). According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.960. [3]
Pharmacological Reviews is a quarterly peer-reviewed scientific journal publishing review articles on all aspects of pharmacology and related topics. It is published by the American Society for Pharmacology and Experimental Therapeutics. The editor-in-chief is Lynette C. Daws (The University of Texas Health Science Center at San Antonio).
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is a monthly peer-reviewed medical journal covering human pharmacology and pharmacotherapy, published by Wiley-Blackwell on behalf of the American College of Clinical Pharmacy, of which it is an official journal.
Pharmaceutical Research is an official journal of the American Association of Pharmaceutical Scientists and covers research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval.
Biochemical Pharmacology is a peer-reviewed medical journal published by Elsevier. It covers research on the pharmacodynamics and pharmacokinetics of drugs and non-therapeutic xenobiotics. The editor-in-chief is Jacques Piette, University of Liege. [1]
The journal was established in 1994 by John Somberg MD and is published by Wolters Kluwer. The editor-in-chief since 2015 is Peter Manu MD, Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, NY. [1] [failed verification] The journal has been part of the Web of Science Core Collection ...
Ad
related to: pharmacology journals with impact factor higher than 10 years